SEYED JALALI to Tumor Burden
This is a "connection" page, showing publications SEYED JALALI has written about Tumor Burden.
Connection Strength
0.385
-
Synergistic effects of anti-PDL-1 with ablative radiation comparing to other regimens with same biological effect dose based on different immunogenic response. PLoS One. 2020; 15(4):e0231507.
Score: 0.155
-
Synergistic antitumor effect of anti-PD-L1 combined with oxaliplatin on a mouse tumor model. J Cell Physiol. 2019 11; 234(11):19866-19874.
Score: 0.145
-
Enhanced immune response induced by P5 HER2/neu-derived peptide-pulsed dendritic cells as a preventive cancer vaccine. J Cell Mol Med. 2018 01; 22(1):558-567.
Score: 0.033
-
P5 HER2/neu-derived peptide conjugated to liposomes containing MPL adjuvant as an effective prophylactic vaccine formulation for breast cancer. Cancer Lett. 2014 Dec 01; 355(1):54-60.
Score: 0.026
-
Effective induction of anti-tumor immunity using p5 HER-2/neu derived peptide encapsulated in fusogenic DOTAP cationic liposomes co-administrated with CpG-ODN. Immunol Lett. 2014 Nov; 162(1 Pt A):87-93.
Score: 0.026